Phase II Study of Efficacy and Safety of HSK39297 Tablet in Treatment of Patients with Primary IgAN

Henagliflozin Delays the Progress of Diabetic Nephropathy Via Regulates Gut-Renal Axis

NCT06031389 ·Status: NOT_YET_RECRUITING ·Phase: NA

Efficacy and Safety Study of Isuzinaxib in Subjects With DKD

NCT06962098 ·Status: RECRUITING ·Phase: PHASE2

To Improve the Ability of Early Screening and Diagnosis in Patients With Diabetic Nephropathy

NCT05047471 ·Status: UNKNOWN

A Study of RTA 402 in Chronic Kidney Disease (CKD) Patients With Type 2 Diabetes Mellitus

NCT01574365 ·Status: TERMINATED ·Phase: PHASE2

A Glomerular Filtration Rate (GFR) Measuring Study of RTA 402 in Chronic Kidney Disease (CKD) Patients With Type 2 Diabetes Mellitus

NCT01572610 ·Status: TERMINATED ·Phase: PHASE2

A Study of BGM0504 in Healthy Participants and Participants With Impaired Renal Function

NCT06929156 ·Status: COMPLETED ·Phase: PHASE1

Intensive Medical Treatment for Nephropathy Caused by Type 2 Diabetes With Hypertension

NCT00407680 ·Status: UNKNOWN ·Phase: PHASE4

A Study of HRS9531 in Participants With Impaired Kidney Function and Healthy Subjects

NCT06246175 ·Status: COMPLETED ·Phase: PHASE1

Pharmacokinetics and Safety Profile of a Single Dose GZR4 in Subjects with Renal Impairment

NCT06547502 ·Status: COMPLETED ·Phase: PHASE1

Forxiga CKD Japan Post-Marketing Surveillance (PMS)

NCT05306210 ·Status: COMPLETED

Effect of Novel Antidiabetic Drug Combined With Angiotensin Receptor/Neprilysin Inhibitor on Urinary Protein

NCT05922852 ·Status: UNKNOWN

Study of CS-3150 in Hypertensive Patients With Type 2 Diabetes and Albuminuria

NCT02807974 ·Status: COMPLETED ·Phase: PHASE3

A Clinical Study to Access the Pharmacokinetics of HMS5552 in Renal Impaired Subjects and Healthy Volunteers

NCT04324424 ·Status: COMPLETED ·Phase: PHASE1

Pharmacokinetic and Safety Studies of HRS-7535 in Subjects With Moderate Renal Insufficiency and Healthy Subjects

NCT06132204 ·Status: COMPLETED ·Phase: PHASE1

A Phase I PK Study of Balcinrenone/Dapagliflozin in Healthy Chinese Participants

NCT06651021 ·Status: COMPLETED ·Phase: PHASE1

A Single Oral Dose Study Of PF-06409577 In Healthy Adult Subjects

NCT02286882 ·Status: TERMINATED ·Phase: PHASE1

Evaluate the Glycemic Control of CKD-501 in Type 2 Diabetes Mellitus

NCT01030679 ·Status: COMPLETED ·Phase: PHASE2

Investigation for Clinical Efficacy and Safety of Ipragliflozin 50mg and 100mg on Type II Diabetes

NCT02317484 ·Status: COMPLETED

SGLT2 Inhibitors As First Line Therapy to Prevent Renal Decline in Type 2 Diabetes

NCT05345327 ·Status: RECRUITING ·Phase: PHASE3

Effect of Dorzagliatin on Renal Function Outcomes in People With Type 2 Diabetes: a Multicentric, Prospective, Randomized Study.

NCT06222476 ·Status: NOT_YET_RECRUITING ·Phase: NA

Study of Safety and Efficacy Of Ertugliflozin (PF-04971729, MK-8835) In Participants With Type 2 Diabetes And Hypertension (MK-8835-042)

NCT01096667 ·Status: COMPLETED ·Phase: PHASE2

Effects of PH3 in Diabetic Nephropathy

NCT01068041 ·Status: COMPLETED ·Phase: PHASE2

Effectiveness and Safety of Finerenone in Chinese CKD Patients Without Diabetes Mellitus

NCT06301022 ·Status: RECRUITING

Pharmacokinetics, Safety and Tolerability of CKD-387 10/500mg BE Phase1

NCT04156685 ·Status: COMPLETED ·Phase: PHASE1

Safety and Effectiveness of Propagermanium in Diabetic Kidney Disease Participants Receiving Irbesartan

NCT03627715 ·Status: COMPLETED ·Phase: PHASE2